This article was originally published in Start Up
Executive SummaryCellular Genomics discovers and validates new drug targets, initially those associated with dendritic cells, T cells, and mast cells. It is carrying out classical cell biology studies in parallel with genomic analysis, thereby correlating changing cellular behavior with changes in patterns of gene expression and in protein modification and localization within the cell.
You may also be interested in...
A series of basic research insights around the cell death process called ferroptosis could form the underpinnings of a new class of treatments aimed at drug resistant tumors.
Recent clinical data using antisense drugs in neurological diseases are encouraging signs that targeting genetic drivers of ALS with antisense oligonucleotides or other gene-altering drugs could halt progression of several forms of the disease.